The Chinese Journal of Clinical Pharmacology 2008 Issue 6 Consideration for clinical efficacy evaluation criterion in guidance for clinical trials of antibacterial agents in China

Consideration for clinical efficacy evaluation criterion in guidance for clinical trials of antibacterial agents in China
ZHAO De-heng;LI Ya-jie;XIE Song-mei;ZHAO Ming;YANG Jin-bo

..............page:564-565

FDA's considerations for anti-bacterial drugs clinical trials for treating complicated urinary tract infections and pyelonephritis
YANG Jin-bo;XIE Song-mei

..............page:566-569

Introduction current situation and research of antimicrobial resistance surveillance in teaching hospitals of China
YANG Qi-wen;WANG Hui;XU Ying-chun;SUN Hong-li;XIE Xiu-li;CHEN Min-jun

..............page:570-573

Requirements for clinical contents presentation of the package insert on antibacterial agents in China
XIE Song-mei;YANG Jin-bo;ZHAO Ming;ZHAO De-heng;LI Ya-jie

..............page:574-576

Discussion on good practices of filing clinical trial's data
LI Jian-ming

..............page:561-563

Analysis clinical trial design of traditional Chinese medicine injections on efficiency
TANG Jian-yuan;WANG Hai-nan

..............page:558-560

Discussion on allergic reactions of traditional Chinese medicine injections and its related research
WANG Hai-nan;TANG Jian-yuan

..............page:555-557

Clinical consideration and trial design seminar about pepetic ulcer and chronic gastritis on traditional Chinese medicine
TANG Jian-yuan;PEI Xiao-jing;DA Hong-yuan;ZHANG Lei

..............page:553-554

Safety assessment of astemizole in cardiovascular system of post marketed
WANG Jun;HU Xia-min;ZENG Fan-dian;HU Xian-min

..............page:549-552

Analysis of the daily drug cost of oral hypolycemic drugs
CHEN Rui-qing;XIE Yi-ru;HUANG Chu-zhu

..............page:546-548

Effects of extractive of chidan on chronic pelvic inflam mation induced by a mixture of bacterium suspension in rats
ZHAO Tie;DONG Fang;MU Xu-yang;JIAN Ling-yan

..............page:543-545

Application of fish oil lipid emulsion for parenteral nutrition in critical illness
ZHANG Jie;GAO Ying-chang;CUI Xiang-li;REN Shu-ping

..............page:539-542

P-glycoprotein mediated drug-drug interaction of central nervous system drugs
SHEN Yuan;LI Huan-de

..............page:533-538

Progress in pharmacokinetics of vancomycin
JI Min-chun;SHEN Xiao-ying;YANG Yao-fang

..............page:529-532

Comparison of domestic and imported voriconazole antifungal activity in vitro
LIU Wei;QIAO Jian-jun;WAN Zhe;CHEN Wei;WANG Duan-li;LI Ruo-yu

..............page:526-528

Pharmacokinetics and bioequiValence of diclofenac sodium sustain-released tablets in healthy volunteers
GUO Hai-jie;WU Hui-zhe;SUN Ming-li;LIU Ming-yan;WEI Min-Jie

..............page:521-525

Pharmacokinetics of fluoxetine hydrochloride enteric-coated tablets after a single oral administration in healthy Chinese volunteers
SHA Sha;LIU Yi;LI Ling-zhi;SUN Li-li;MA Wen-bin;ZHANG Hong-yan

..............page:517-520

Bioequivalence of verapamil hydrochloride delayed release tablets and its common tablets in healthy volunteers
QIU Feng;ZHAO Li-mei;SUN Ya-xin;HE Xiao-jing

..............page:513-516

Pharmacokinetics and relative bioavailability of glucosamine hydrochloride granules in Chinese healthy volunteers
ZHOU Yan-wen;XU Ai-lan;LAN Cong-xian

..............page:509-512

Pharmacokinetics and bioequivalence of calcium dobesilate granules in healthy volunteers
XIA Su-xia;TANG Si;WANG Yue-min;XING Xiao-chen;ZHANG Shi-liang

..............page:505-508

Comparative clinical trial of the traditional Chinese medicine hypoglycemic composing prescription and metformin in the treatment of type 2 diabetes mellitus
LIAN Feng-mei;TONG Xiao-lin;BAI Yu;ZHAO Yu;YAO Chen

..............page:501-504

Effects of genetic polymorphisms of CYP2C19,CYP3A5 and MDR1 on the pharmacokinetics of lansoprazole
XIANG Qian;LIU Yu-wang;ZHAO Xia;ZHOU Ying;SUN Pei-hong;CUI Yi-min

..............page:497-500

Efficacy and safety of risedronate in the prevention and treatment of postmenopausal osteoporosis
LIU Yong;FAN ji-yuan;CHEN De-cai;YAN Sheng-li;WANG Li;YANG Ding-zhuo

..............page:493-496

Tolerance of recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein for injection
SHAO Wei;WEN Ai-dong;SUN Xiao-li

..............page:490-492

Randomized,double-blind,controlled cllinical trial of effects of recombinant human erythropoietin on the antiplatelet effects of aspirin and clopidogrel in healthy subjects
TANG Yi-da

..............page:483-489